2020 annual financial data

CytomX Therapeutics 2020 Financial results

Direct answer

Revenue was 68,427,000 USD.

Operating income was -80,540,000 USD and net income was -64,819,999 USD.
Operating cash flow was 5,259,000 USD.

Get free CytomX Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
68,427,000 USD
Operating income
-80,540,000 USD
Net income
-64,819,999 USD
Operating cash flow
5,259,000 USD